Press Releases

 Filter by Provider

From combat zone extensions to disability pay exclusions, veterans have access to tax provisions that most never claim.

Agreement strengthens MineHub's presence in Asia and expands digital transparency for global metals supply chains.Vancouver, British Columbia--(Newsfile Corp. - May...

Vancouver, British Columbia--(Newsfile Corp. - May 13, 2026) - Hemisphere Energy Corporation (TSXV: HME) (OTCQX: HMENF) ("Hemisphere" or the "Company") declares...

- CDMO program advances to Stage 2 of development agreement valued at $1.125 million-Advancement of sustainable solution for the production...

Twelve Northwell Health hospitals have received four-star or better ratings from the Centers for Medicare and Medicaid Services (CMS) – seven of them earning five stars – as part of its 2026 CMS Star Quality Rating System, which were announced Wednesday. This marks the first time that seven Northwell hospitals earned the highest rating.

The LYCRA Company, a leader in innovative and sustainable fibers for apparel and personal care, today announced the official global launch of LYCRA® ADAPTIV fiber for nonwovens at INDEX™ 26, in Geneva, Switzerland, May 19–22.

Charles River Laboratories (CRL) and MEDIPOST Co., Ltd. (KOSDAQ 078160) have entered into a strategic, non-exclusive Memorandum of Understanding (MOU) to collaborate on GMP-compliant testing, as well as broader commercial and marketing efforts to advance cell therapy development and commercialization. The partnership will leverage Charles River’s expertise in biologics and cell therapy GMP testing to support MEDIPOST’s global cell therapy pipeline, starting in the Asia-Pacific (APAC) and North America (NA) regions, with possible expansion into Middle East and Europe.

ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced the expansion of its early phase capabilities with the opening of a new, state-of-the-art Clinical Research Unit (CRU) in San Antonio, Texas, as well as new satellite outpatient clinics in Houston, Texas and Lawrence, Kansas. These new, purpose-built clinics will significantly expand ICON’s capacity to conduct first-in-human, healthy participant, and patient cohort studies.

Sprinklr (NYSE: CXM), the definitive, AI-native platform for Unified Customer Experience Management (Unified-CXM), today announced that the company’s first quarter financial results will be released before market open on June 3, 2026. The company’s earnings press release will be made available on the Sprinklr Investor Relations website at investors.sprinklr.com.

Guitar Center today named Jennifer Hatton President of Music & Arts, the company's school music division. Hatton brings nearly three decades of education sector leadership, most recently as Chief Growth Officer at Aramark Collegiate Hospitality, where she helped secure more than $240 million in new business partnerships and achieved a 98% account renewal and retention rate over the last 18 months. Her appointment positions Music & Arts to accelerate growth across its school music, rental, and lessons businesses.

Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Select Medical Holdings Corporation (NYSE: SEM) approved a buyout of Select Medical Holdings for inadequate consideration, breaching their fiduciary duties to Select Medical Holdings’s shareholders, and whether Select Medical Holdings’s shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know:

QuSecure™, Inc., a leader in post-quantum cryptography (PQC) and cryptographic agility, today announced it was named one of 10 finalists for the 2026 MIT Sloan CIO Symposium Innovation Showcase, taking place May 18 – 19 in Cambridge, Mass. QuSecure will present QuProtect R3™, its crypto-agile platform for managing enterprise post-quantum migration without no code or infrastructure changes.

Infinimmune, a biotechnology company pioneering antibody discovery and design, today announced the appointment of Srikanth Pendyala, M.D., as Chief Medical Officer. In this role, Dr. Pendyala will lead clinical and regulatory strategy across Infinimmune’s pipeline, including first-in-human trials of IFX-101 and IFX-201.

Modelithics®, the leading provider of high-accuracy RF and microwave simulation models, today announced that new high-power GaN models from Guerrilla RF, Inc. (OTCQX: GUER) — a leading provider of high-performance radio frequency (RF) and microwave semiconductors — have been added to the Modelithics COMPLETE Library™. These new nonlinear models were developed through Guerrilla RF’s collaboration with Modelithics via the Sponsoring MVP (Modelithics Vendor Partner) Program.

Elpida Therapeutics, a non-profit biotechnology company developing gene therapies for ultra-rare diseases, and Catalent, Inc., the leader in enabling the development and supply of better treatments for patients worldwide, today announced a strategic partnership to support late-phase manufacturing of Elpida’s lead program, an AAV9 gene therapy for Spastic Paraplegia Type 50 (SPG50). Under the agreement, Catalent will also be granted exclusive manufacturing rights to Elpida’s other pipeline adeno-associated virus (AAV) gene therapy programs.

Coty Inc. (NYSE: COTY) (Paris: COTY), (“Coty” or “the Company”) one of the world's largest beauty companies, today announced that its enterprise AI literacy program, "Supercharge with AI: Scaling Enterprise-Wide AI Literacy & Adoption to Transform How Coty Works," (Supercharge with AI), has been named a winner of Newsweek’s AI Impact Award in the “AI Workplace: Best Outcomes, Employee Engagement” category. The award program recognizes organizations applying artificial intelligence to drive innovation, improve operations, solve complex challenges, and create measurable business or societal impact.

Starfighters Space, Inc. ("Starfighters" or the "Company") (NYSE American: FJET), the innovative aerospace company, owner and operator of the world's largest fleet of commercial supersonic aircraft, announced today that it has engaged Integrated Launch Solutions, Inc. ("ILS") to provide engineering and technical integration support as Starfighters advances the STARLAUNCH pathway from design and analysis toward flight and launch services.

Gold Reserve Ltd. (TSX.V: GRZ) (BSX: GRZ.BH) (OTCQX: GDRZF) (“Gold Reserve” or the “Company”) is pleased to announce that its board of directors has approved the previously announced potential spin-out (the “American Heralds Spin-Out”) of its new U.S.-domiciled company, American Heralds Mining Corporation (“American Heralds”). As described in the Company’s prior news release, it is intended that American Heralds will hold Gold Reserve’s mining interests in Venezuela (including the Company’s ongoing efforts to pursue its interest in the Siembra Minera project) and its Alaskan property.

PRISM Vision Group (PRISM), a leading provider of general ophthalmology and retina practice management services, announced that it closed a transaction with Retina Macula Institute (RMI), through which RMI joins PRISM Vision Group’s network of affiliated practices focused on advancing high‑quality, patient‑centered eye care.

Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today reported financial results for the first quarter ended March 31, 2026 and provided corporate updates.

Press Ganey, a leading provider of experience measurement, data analytics, and AI-powered insights to health systems and health plans, today released the findings of its annual signature report, State of Nursing 2026. Drawing on one of the largest and most comprehensive nursing datasets in the industry, spanning more than 500,000 nurses and advanced practice providers (APPs), the report shows that while engagement has begun to stabilize, the recovery is fragile and uneven.

TechBlocks, a global leader in AI-native transformation and digital engineering, today announced an expanded partnership with Factory, a leading agent-native software development platform. Factory builds software development agents called Droids that automate and accelerate the world's largest enterprise engineering teams. The partnership reflects a significant step forward in how TechBlocks industrializes software engineering, combining its AI operating model, accelerators, and enterprise delivery framework with Factory’s autonomous Droids to help enterprise clients build, modernize, and scale software systems faster and more efficiently.

As the U.S. prepares to celebrate its 250th anniversary, The Westin Maui Resort & Spa, Kāʻanapali invites guests and kama‘āina to commemorate the milestone in a uniquely Hawai‘i way with a celebration that trades traditional fireworks for an environmentally-conscious spectacle.

Calyxo, Inc., a medical device company redefining kidney stone treatment, will arrive at the American Urological Association (AUA) Annual Meeting with strong clinical momentum, supported by an expanded evidence base and increasing adoption of the CVAC System in practice. At this year’s meeting, 10 abstracts, the highest number presented to date, will highlight safety, efficacy, and procedural efficiency, alongside multiple opportunities for hands-on, physician-led education. AUA2026 takes place May 15–18 in Washington, DC.

Lantern Pharma Inc. (NASDAQ: LTRN) (“Lantern” or the “Company”), a clinical-stage AI-driven precision oncology company developing targeted and transformative cancer therapies using its proprietary AI and machine learning platforms with multiple clinical stage drug programs, today announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 2,135,923 shares of its common stock (or pre-funded warrants in lieu thereof) at a purchase price of $2.06 per share (or pre-funded warrant in lieu thereof) in a registered direct offering. In addition, in a concurrent private placement, the Company will issue unregistered warrants to purchase up to 2,135,923 shares of common stock. The warrants will have an exercise price of $2.27 per share, will be exercisable six months following the initial issuance date, and will expire five years following the initial exercise date. The closing of the offering is expected to occur on or about May 14, 2026, subject to the satisfaction of customary closing conditions.

Pipedrive, the easy and intelligent CRM for small and medium-sized businesses (SMBs), has launched a new Canada-based data centre in Montreal, marking the addition of its seventh global hosting region. The new deployment improves performance and enables Canadian data residency for local customers. The launch follows Pipedrive’s recent expansion into Australia and reflects a broader shift toward regional infrastructure in high-growth markets, driven by increasing demand for both performance and local data hosting.

CRH (NYSE: CRH), the leading provider of building materials, announced the appointment of Aylwyn Bryan as its Chief Financial Officer, effective May 12, 2026.

Adtran today announced an expansion of its SDG 8700 Series, extending Wi-Fi 7 across a broader range of residential service tiers and deployment models. The expanded portfolio introduces new 2.5Gbit/s and 10Gbit/s Wi-Fi 7 platforms designed to support the full spectrum of multigigabit services – from entry-level offerings to premium tiers – across residential, SMB, MDU and community Wi-Fi deployments. As service providers enter a new access refresh cycle, Wi-Fi 7 is rapidly becoming a baseline requirement rather than a premium differentiator. Adtran’s expanded SDG 8700 portfolio enables providers to deploy next-generation Wi-Fi more broadly and consistently without compromising subscriber experience or changing operational models. The launch also builds on the FCC’s recent conditional approval of Adtran’s SDG portfolio, supporting continued broadband rollout momentum.

Assertio Holdings, Inc. (Nasdaq: ASRT) (“Assertio” or the “Company”) today announced that, following an engagement process outlined under the revised merger agreement (the “Garda Merger Agreement”) with Garda Therapeutics, Inc. (“Garda”), the Company’s Board of Directors (the “Board”) approved a definitive agreement with Zydus Worldwide DMCC, a subsidiary of Zydus Lifesciences Limited (“Zydus”) to acquire all outstanding shares of Assertio common stock for $23.50 per share in cash, representing total consideration of approximately $166.4 million (the “Zydus Offer”). The Board determined that the Zydus Offer constituted a “Superior Proposal” under the Garda Merger Agreement and authorized the Company to terminate the Garda agreement announced on May 4, 2026 and enter into the transaction with Zydus (the “Zydus Transaction”).

GLM III, LP (“GLM III”) and its affiliated investment manager GoldenTree Asset Management LP (along with other affiliated investment managers “GoldenTree”), announced the closing of a $602 million collateralized loan obligation (“CLO”) to be managed by GLM III. With the closing of this CLO, GoldenTree Loan Management US CLO 29 (“GLM US CLO 29”), GoldenTree has issued 38 CLOs totaling over $21 billion under its GLM CLO strategy. Since its inception in January 2017, the GLM strategy was intended to be compliant with applicable Risk Retention regulations. While a US Court of Appeals on February 9, 2018 held that the U.S. risk retention rules do not apply to collateral managers of open market CLOs, GLM CLOs have intended to comply with European Union and/or United Kingdom Risk Retention regulations.

Clari + Salesloft, the leader in the Revenue Orchestration, today announced the appointments of Brian Benfer as Chief Revenue Officer (CRO) and Rajesh Krishnaswami as Chief Technology Officer (CTO), strengthening both the execution engine that drives revenue and the AI platform that powers it.

Norwest Equity Partners (“NEP”), a leading middle-market investment firm, today announced the sale of Thibaut (or the “Company”), a premier designer and distributor of luxury wallcoverings, fabrics, rugs and furniture, to Quad-C Management, Inc. (“Quad-C”).

Overall satisfaction with home improvement retailers held steady in 2026, rising 1 point from 2025 to 672 (on a 1,000‑point scale), according to the JD Power 2026 U.S. Home Improvement Retailer Satisfaction StudySM released today. Shoppers indicate better product availability, improved digital tools and enhanced operational services such as clinics, rentals, delivery, installation and reward programs. Conversely, higher spending is making shoppers more sensitive to value. The average amount spent at home improvement retailers in 2026 reached $1,617, an increase of $278 compared with 2025.

XBOW, the leader in autonomous offensive security, today announced that it has joined the Amazon Web Services (AWS) Independent Software Vendor (ISV) Accelerate Program, a co-sell program for AWS Partners that provides software solutions that run on or integrate with AWS. The program helps AWS Partners drive new business by directly connecting participating ISVs with the AWS Sales organization.

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced that the United States Patent and Trademark Office (USPTO) issued to Enveric US Patent No. 12,605,361 (the ’361 patent), titled, “Carboxylated Psilocybin Derivatives and Methods of Using,” pertaining to the Company’s EVM301 Series of molecules being developed as potential treatments for mental health disorders.

Jim Vena, chief executive officer and Jennifer Hamann, executive vice president and chief financial officer, of Union Pacific Corporation (NYSE: UNP) will address the Wolfe Research 19th Annual Global Transportation & Industrials Conference on Wednesday, May 20, 2026, at 9:50 a.m. ET.

Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced that it will host Evolv Technology Investor Day 2026 on Tuesday, June 9, 2026 from 9:00 a.m. to 12:00 p.m. Eastern Time. Members of the Company’s management team will provide an overview of the Company's vision, strategy, growth initiatives, business trends, products and technology as well as its financial goals. Evolv Technology Investor Day 2026 will be webcast live at http://ir.evolvtechnology.com.

Brithem LLP has filed a lawsuit in the United States District Court for the Central District of California alleging that The Toyota Mobility Foundation (TMF) and its outside consultants misappropriated trade secrets and other proprietary information of the small Zimbabwean social enterprise company Mobility for Africa (MFA), which is dedicated to improving the lives of African women and rural communities by providing a sustainable ecosystem of EV mobility. The complaint alleges that TMF and its consultants induced access to MFA’s intellectual property by promising to joint venture with MFA in providing similar mobility solutions throughout Africa. After securing that access, however, TMF and its outside consultants abandoned MFA financially and excluded it from their ongoing mobility efforts that they launched and expanded using MFA’s hard-earned intellectual property. Taking full credit for the solution, TMF bolstered its reputation and goodwill in Africa while its consultants used that technology in for-profit ventures.

For Five Coffee Roasters ("For Five"), a leading vertically integrated specialty coffee roaster, retailer, and wholesale provider, announced that it has raised a significant growth investment from a select group of strategic investors. The capital will support the Company’s continued expansion of production capacity at its Queens roasting facility, accelerate the build-out of new retail cafes across metropolitan markets, and further scale its wholesale and hospitality divisions.

Mongoose AI today launched a new category of governed AI agents purpose-built for health plans, alongside an oversubscribed seed extension co-led by Vertical Venture Partners (VVP). The platform is already in production and implementation with a growing roster of customers across the health plan ecosystem, with workflows spanning employer, broker, member and provider services. The seed extension included Overstory Partners, Connecticut Innovations as well as a roster of strategic healthcare executives onto the company’s cap table, including a cohort of former and current chief information officers and customer-experience executives from national and regional health plans.

Revvity, Inc., through its subsidiary, Immunodiagnostic Systems (IDS), today announced that it received clearance from the U.S. Food and Drug Administration (FDA) for its Total Testosterone automated chemiluminescence immunoassay (ChLIA). This offering complements the Company’s FDA-cleared ChLIA tests for free testosterone and sex hormone-binding globulin (SHBG), delivering a first of its kind, complete solution for testosterone-related disorders on a single platform.

NiCE (Nasdaq: NICE) NiCE today announced a strategic partnership with Konecta, a global leader in customer experience (CX) and digital services, to accelerate the deployment of next-generation, AI-powered solutions across global markets.

Avant Genomics™, a pioneer in fully-automated liquid biopsy sample preparation for precision cancer detection, today announced the successful raise of more than $3 million to advance development of its automated platform for liquid biopsy sample preparation. TitletownTech, Halyard Ventures, Virginia Venture Partners, CAV Angels, Global Impact Fund, and additional angel investors and family offices participated in the round. The new capital will support continued R&D, accelerate manufacturing, and expand the team’s expertise with additional hires.

SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering patients and their caregivers to better protect against severe allergic reactions that can lead to anaphylaxis, today announced the appointment of Donn Casale as President, effective June 1, 2026. Richard Lowenthal will continue to lead ARS Pharma as Chief Executive Officer.

TORONTO, May 13, 2026 (GLOBE NEWSWIRE) -- BLiNQ Networks announces the expansion of its outdoor Small Cell portfolio with two solutions designed to support scalable Private 5G deployments: the high power MCRF-400 and mid power PCW-400.

MONTREAL, May 13, 2026 (GLOBE NEWSWIRE) -- Gildan Activewear Inc. (GIL: TSX and NYSE) (“Gildan” or “the Company”) is pleased to announce the publication of its 22nd Sustainability Report¹, highlighting progress under its Next Generation Sustainability strategy² and ongoing efforts to create long-term value.

VANCOUVER, British Columbia, May 13, 2026 (GLOBE NEWSWIRE) -- NOVAGOLD RESOURCES INC. (“NOVAGOLD” or the “Company”) (NYSE American, TSX: NG) is pleased to announce the publication of its 2025 Sustainability Report which provides an overview of the Company’s performance in the areas of environmental responsibility, health and safety, social engagement, and corporate governance in alignment with the recommendations of the TCFD, the TNFD and GRI standards.

WALTHAM, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF), today announced that management will participate in a fireside chat at the 2026 RBC Capital Markets Global Healthcare Conference on Wednesday, May 20th, 2026, at 2:05 p.m. ET.

Showcasing rugged AI Compute Solutions “Built for the edge, engineered for the fight” at Booth #5006

SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Antonio F. Santidrian, PhD, Chief Scientific Officer and Head of Technical Operations for Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or “the Company”), a biotechnology company pioneering the development of targeted genetic medicines, will speak tomorrow at the annual conference of the American Society for Gene and Cell Therapy (ASGCT) in Boston, Massachusetts. Dr. Santidrian was invited to speak at the conference and detail the exciting promise of Calidi’s RedTail platform and pipeline. The Company’s proprietary RedTail platform is a systemically delivered virotherapy platform engineered to selectively target tumors, remodel the tumor microenvironment (“TME”), and enable high-level expression of therapeutic genetic payloads directly within tumors.